uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
[111In-DPTA-D-Phe1] - Octreotide Scintigraphy in the Management of Patients with Advanced Renal Cell Carcinoma
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi, Enheten för onkologi.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi, Enheten för onkologi.
(Uppsala University Pet-Centre)
(Uppsala University Pet-Centre)
Vise andre og tillknytning
1999 (engelsk)Inngår i: Cancer Biotherapy and Radiopharmaceuticals, ISSN 1084-9785, E-ISSN 1557-8852, Vol. 14, nr 1, s. 59-64Artikkel i tidsskrift (Annet vitenskapelig) Published
Abstract [en]

Somatostatin receptor scintigraphy using the 111In-labelled somatostatin analogue octreotide (Octreoscan) was performed in 9 patients with metastatic renal cell carcinoma. In total 11 scintigraphies were performed. Positive tumor uptakes were observed in 9 patients. The results of the octreotide scans were correlated to diagnostic CT and/or X-ray images. Forty (59%) out of 68 known tumor localizations were visualized with the octreotide scan. A second scan following therapy was performed in two patients. These patients showed progressive disease despite treatment and also exhibited intensified uptakes at octreotide scintigraphy. One false positive lesion was observed in the 40 lesions visualized in scintigraphy.

It was concluded that renal cell carcinoma expresses somatostatin receptors, as could be visualized with Octreoscan scintigraphy. The scintigraphic technique can be used as an instrument for in vivo characterization of the disease. The data could also form a basis for future investigations regarding the possible therapeutic effect of octreotide in the management of renal cell cancer.

sted, utgiver, år, opplag, sider
1999. Vol. 14, nr 1, s. 59-64
Emneord [en]
Aged, Carcinoma; Renal Cell/pathology/radiography/*radionuclide imaging, Comparative Study, Disease Progression, Evaluation Studies, Female, Humans, Indium Radioisotopes/*diagnostic use, Kidney Neoplasms/pathology/radiography/*radionuclide imaging, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Proteins/*analysis, Receptors; Somatostatin/*analysis, Research Support; Non-U.S. Gov't, Somatostatin/*analogs & derivatives/diagnostic use, Tomography; X-Ray Computed, Tumor Markers; Biological
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-73667DOI: 10.1089/cbr.1999.14.59PubMedID: 10850288OAI: oai:DiVA.org:uu-73667DiVA, id: diva2:101577
Tilgjengelig fra: 2005-06-13 Laget: 2005-06-13 Sist oppdatert: 2017-12-14bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=10850288&dopt=Citation

Personposter BETA

Edgren, MalihaSundin, AndersNilsson, Sven

Søk i DiVA

Av forfatter/redaktør
Edgren, MalihaSundin, AndersNilsson, Sven
Av organisasjonen
I samme tidsskrift
Cancer Biotherapy and Radiopharmaceuticals

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 582 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf